UW Health urges cancer screening appointments amid pandemic fox6now.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from fox6now.com Daily Mail and Mail on Sunday newspapers.
In a report published Monday, Morgan Stanley analyst David Risinger and his team reiterated an Overweight rating on Bristol-Myers Squibb Co (NYSE: BMY) after the National Comprehensive Cancer Network (NCCN) updated its guidelines for the treatment of Non-Small Cell Lung Cancer (NSCLC) to. Read More. Don t Miss Any Updates! News Directly in Your Inbox Subscribe to:
Operator
Greetings and welcome to the TG Therapeutics Fourth Quarter and Year-End 2020 Conference Call. [Operator Instructions] A question-and-answer session will follow the formal presentation. [Operator Instructions]
I would now like to turn the conference over to your host, Jenna Bosco, Senior Vice President of Corporate Communications. Please go ahead.
Jenna Bosco
Senior Vice President of Corporate Communications
Thank you. Welcome everyone, and thanks for joining us this morning. I m Jenna Bosco and with me today to discuss the fourth quarter and year-end 2020 financial results and provide a business update are Sean Power, our Chief Financial Officer; Michael Weiss, our Executive Chairman and Chief Executive Officer; and Adam Waldman, our Chief Commercialization Officer.